Global Narcolepsy Market 2020 Research Forecast 2026

Published On: Dec 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 85552

Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
In 2020, the global Narcolepsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Narcolepsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Narcolepsy development in United States, Europe and China.

The key players covered in this study
Jazz Pharmaceuticals
Bioprojet
Arena Pharmaceuticals
Graymark Healthcare
Mylan
Teva Pharmaceutical Industries
Novartis
Shire
Shionogi
Ligand Pharmaceuticals

Market segment by Type, the product can be split into
Type 1 Narcolepsy
Type 2 Narcolepsy

Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Narcolepsy status, future forecast, growth opportunity, key market and key players.
To present the Narcolepsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Narcolepsy are as follows:
History Year: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Narcolepsy Market Size Growth Rate by Type (2015-2026)
1.4.2 Type 1 Narcolepsy
1.4.3 Type 2 Narcolepsy
1.5 Market by Application
1.5.1 Global Narcolepsy Market Share by Application (2015-2026)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Narcolepsy Market Size
2.2 Narcolepsy Growth Trends by Regions
2.2.1 Narcolepsy Market Size by Regions (2015-2026)
2.2.2 Narcolepsy Market Share by Regions (2015-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Narcolepsy Market Size by Manufacturers
3.1.1 Global Narcolepsy Revenue by Manufacturers (2015-2020)
3.1.2 Global Narcolepsy Revenue Market Share by Manufacturers (2015-2020)
3.1.3 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
3.2 Narcolepsy Key Players Head office and Area Served
3.3 Key Players Narcolepsy Product/Solution/Service
3.4 Date of Enter into Narcolepsy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Narcolepsy Market Size by Type (2015-2020)
4.2 Global Narcolepsy Market Size by Application (2015-2020)

5 United States
5.1 United States Narcolepsy Market Size (2015-2020)
5.2 Narcolepsy Key Players in United States
5.3 United States Narcolepsy Market Size by Type
5.4 United States Narcolepsy Market Size by Application

6 Europe
6.1 Europe Narcolepsy Market Size (2015-2020)
6.2 Narcolepsy Key Players in Europe
6.3 Europe Narcolepsy Market Size by Type
6.4 Europe Narcolepsy Market Size by Application

7 China
7.1 China Narcolepsy Market Size (2015-2020)
7.2 Narcolepsy Key Players in China
7.3 China Narcolepsy Market Size by Type
7.4 China Narcolepsy Market Size by Application

8 Japan
8.1 Japan Narcolepsy Market Size (2015-2020)
8.2 Narcolepsy Key Players in Japan
8.3 Japan Narcolepsy Market Size by Type
8.4 Japan Narcolepsy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Narcolepsy Market Size (2015-2020)
9.2 Narcolepsy Key Players in Southeast Asia
9.3 Southeast Asia Narcolepsy Market Size by Type
9.4 Southeast Asia Narcolepsy Market Size by Application

10 India
10.1 India Narcolepsy Market Size (2015-2020)
10.2 Narcolepsy Key Players in India
10.3 India Narcolepsy Market Size by Type
10.4 India Narcolepsy Market Size by Application

11 Central & South America
11.1 Central & South America Narcolepsy Market Size (2015-2020)
11.2 Narcolepsy Key Players in Central & South America
11.3 Central & South America Narcolepsy Market Size by Type
11.4 Central & South America Narcolepsy Market Size by Application

12 International Players Profiles
12.1 Jazz Pharmaceuticals
12.1.1 Jazz Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Narcolepsy Introduction
12.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
12.1.5 Jazz Pharmaceuticals Recent Development
12.2 Bioprojet
12.2.1 Bioprojet Company Details
12.2.2 Company Description and Business Overview
12.2.3 Narcolepsy Introduction
12.2.4 Bioprojet Revenue in Narcolepsy Business (2015-2020)
12.2.5 Bioprojet Recent Development
12.3 Arena Pharmaceuticals
12.3.1 Arena Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Narcolepsy Introduction
12.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
12.3.5 Arena Pharmaceuticals Recent Development
12.4 Graymark Healthcare
12.4.1 Graymark Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Narcolepsy Introduction
12.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2015-2020)
12.4.5 Graymark Healthcare Recent Development
12.5 Mylan
12.5.1 Mylan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Narcolepsy Introduction
12.5.4 Mylan Revenue in Narcolepsy Business (2015-2020)
12.5.5 Mylan Recent Development
12.6 Teva Pharmaceutical Industries
12.6.1 Teva Pharmaceutical Industries Company Details
12.6.2 Company Description and Business Overview
12.6.3 Narcolepsy Introduction
12.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2015-2020)
12.6.5 Teva Pharmaceutical Industries Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Narcolepsy Introduction
12.7.4 Novartis Revenue in Narcolepsy Business (2015-2020)
12.7.5 Novartis Recent Development
12.8 Shire
12.8.1 Shire Company Details
12.8.2 Company Description and Business Overview
12.8.3 Narcolepsy Introduction
12.8.4 Shire Revenue in Narcolepsy Business (2015-2020)
12.8.5 Shire Recent Development
12.9 Shionogi
12.9.1 Shionogi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Narcolepsy Introduction
12.9.4 Shionogi Revenue in Narcolepsy Business (2015-2020)
12.9.5 Shionogi Recent Development
12.10 Ligand Pharmaceuticals
12.10.1 Ligand Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Narcolepsy Introduction
12.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
12.10.5 Ligand Pharmaceuticals Recent Development

13 Market Forecast 2020-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2020-2026)
13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details